Web
|
Images
|
News
News Home
US
World
Business
Finance
Industry
Technology
Science
Media & Advertising
Politics/Law
Entertainment
Internet
Health
Sports
Culture
Log In
Sales of Vancouver biotech's eye drug continue to decline as global competition
Have an interest in this Story?
Sign Up for Real-Time email updates
Business In Vancouver
|
July 19, 2008
Sales of QLT Inc.'s (TSX:QLT) macular degeneration drug continued to fall in the second quarter of 2008. Global Visudyne sales dropped 31.5% to US$40.7 million for the quarter ending June 30 from US$59.3 million in 2007's second quarter. The drop in Visudyne sales was attributed to competition in Eu...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Log in
|
Register
Most Read World Articles
Obama picks Daschle for health secretary
- Wichita Eagle
Cabinet Picks Demonstrate Obama's Loyalty, Practicality
- Washington Post
IMF loans Iceland $2.1bn
- In The News.co.uk
Fitch Rates San Francisco (California) Int'l $90MM Airport Revs 'F1'
- DiGiTAL50
Democrats want Big Three spending plan
- CNN
Featured Members
David Hood
Director
Marketing/Public Relations
Mark Palmer
Founder
Internet consultancies
View more profiles
Access dozens of premium and subscriptions sites
Free!
Download now
.
Advertise
|
Build a News Circle
|
Get News Briefings
|
Congoo News Home
|
Get the Netpass
About Congoo
|
Terms
|
Privacy
|
Need Help?
|
Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.